昊海生科控股股东、实控人之一蒋伟因涉内幕交易被处罚,公司称蒋伟不参与公司日常经营管理,处罚与公司无关投资时间网、标点财经研究员 李路近日,“玻尿酸三巨头”之一上海昊海生物科技股份有限公司(下称昊海生科,688366.SH;股票简称:昊海生物科技,6826.HK)发布公告称,公司控股股东、实际控制人之一蒋伟收到中国证监会出具的《行政处罚事先告知书》。公告强调,该处罚源于今年5月8日蒋伟因涉嫌内幕交易...
Source Link昊海生科控股股东、实控人之一蒋伟因涉内幕交易被处罚,公司称蒋伟不参与公司日常经营管理,处罚与公司无关投资时间网、标点财经研究员 李路近日,“玻尿酸三巨头”之一上海昊海生物科技股份有限公司(下称昊海生科,688366.SH;股票简称:昊海生物科技,6826.HK)发布公告称,公司控股股东、实际控制人之一蒋伟收到中国证监会出具的《行政处罚事先告知书》。公告强调,该处罚源于今年5月8日蒋伟因涉嫌内幕交易...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.